Home › Asthma › Pennsylvania › Philadelphia
Asthma clinical trials in Philadelphia, PA
4 studies for Asthma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)
RecruitingPhase 3
- GSK Investigational Site, Philadelphia
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
RecruitingPhase 3
- Research Site, Wilmington · 25 mi away
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
RecruitingPhase 2
- Research Site, Philadelphia
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RecruitingPhase 3
- GSK Investigational Site, Philadelphia
About Asthma
Asthma is a chronic lung disease. It causes asthma attacks, which make your airways inflamed and narrowed, and your lungs get less air. Learn about treatments.
More about Asthma on MedlinePlus
Asthma trials in other cities
- Miami, FL13 studies
- New York City, NY11 studies
- Boston, MA11 studies
- The Bronx, NY10 studies
- Dallas, TX10 studies
- Houston, TX9 studies
- Kansas City, KS9 studies
- Durham, NC9 studies
- St. Louis, MO9 studies
- Oklahoma City, OK9 studies
- Washington, DC9 studies
- Charlotte, NC7 studies
Other studies in Philadelphia
- Cancer (all types)57 studies
- Breast Cancer51 studies
- Non-Small Cell Lung Cancer49 studies
- Ovarian Cancer47 studies
- Metastatic Cancer42 studies
- Colorectal Cancer41 studies
- Prostate Cancer41 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia33 studies
- Heart Failure31 studies
- Endometrial Cancer29 studies
- Pancreatic Cancer26 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.